| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |